Tag: Cancer: Lymphoma
ASH: PET Helps Tailor Therapy in Limited-Stage DLBCL
Most patients had negative PET scan and completed one additional R-CHOP cycle without radiation
Risk for Hodgkin Lymphoma Increased With Allergic Disease, Eczema
Associations attenuated but remained significant after adjustment for steroid use
Testosterone Replacement May Benefit Younger Male Cancer Survivors
Benefits include significant improvement in body composition measurements over six months
Predictors of Immune Response to Hep B Shot ID’d in Lymphoma
Dose and frequency of vaccination, sex, Ann Arbor stage, ibrutinib impact immunity effects of vaccine
Risk for Secondary Primary Cancer Varies With Lymphoma Stage
Risk for SPMs differs over time for survivors of diffuse large B-cell lymphoma according to stage at diagnosis
Factors Predict Low BMD in Pediatric Blood Cancer Survivors
Low bone mineral density detected during guideline-recommended dual-energy X-ray absorptiometry
Severe Adverse Cardiovascular Events Associated With Ibrutinib
Risk up for severe, sometimes fatal, events, including supraventricular arrhythmias, CNS events
Incidence of Hodgkin Lymphoma Up in Least Deprived Areas
Linear trend found toward increasing Hodgkin lymphoma incidence with decreasing deprivation
Hematological Malignancy Risk Up for First-Degree Relatives
Increased familial relative risks for the same tumor type for most hematological malignancies
Medicare to Cover CAR-T Therapy for Leukemia, Lymphoma
Chimeric antigen receptor T-cell therapy boosts a patient's own immune cells
